Research Design Service: West Midlands
« back

Action Medical Research for Children: Joint translational funding from AMR and LifeArc

  Tuesday, 21 Jun 2022 | Funding Deadline

Action Medical Research and LifeArc want to improve the lives of children suffering from rare disease and are working together to co-fund translational, rare disease research projects. Co-funding aims to accelerate promising, cutting-edge medical research that could have a significant impact on the treatment of infants, children and young people (CYP) with any of the >7000 heterogeneous conditions collectively called ‘rare disease’.

The joint fund will be used to support biomedical research projects from across the UK that have moved beyond a basic understanding of rare disease mechanism into the development of an intervention (therapeutic, diagnostic, or device). Applications should:

  • address a significant, unmet need for children and young people (CYP) with rare disease
  • have a strong scientific rationale
  • be target-driven, with a credible delivery plan and milestones
  • have a clear route to patients.

Deadline for proposals: 21 June 2022
Find out more here